Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency.

Abstract:

:Suberoylanilide hydroxamic acid (SAHA) has been assessed in clinical trials as part of a "shock and kill" strategy to cure HIV-infected patients. While it was effective at inducing expression of HIV RNA ("shock"), treatment with SAHA did not result in a reduction of reservoir size ("kill"). We therefore utilized a combined analysis of effects of SAHA on the host transcriptome and proteome to dissect its mechanisms of action that may explain its limited success in "shock and kill" strategies. CD4+ T cells from HIV seronegative donors were treated with 1μM SAHA or its solvent dimethyl sulfoxide (DMSO) for 24h. Protein expression and post-translational modifications were measured with iTRAQ proteomics using ultra high-precision two-dimensional liquid chromatography-tandem mass spectrometry. Gene expression was assessed by Illumina microarrays. Using limma package in the R computing environment, we identified 185 proteins, 18 phosphorylated forms, 4 acetylated forms and 2982 genes, whose expression was modulated by SAHA. A protein interaction network integrating these 4 data types identified the HIV transcriptional repressor HMGA1 to be upregulated by SAHA at the transcript, protein and acetylated protein levels. Further functional category assessment of proteins and genes modulated by SAHA identified gene ontology terms related to NFκB signaling, protein folding and autophagy, which are all relevant to HIV reactivation. In summary, SAHA modulated numerous host cell transcripts, proteins and post-translational modifications of proteins, which would be expected to have very mixed effects on the induction of HIV-specific transcription and protein function. Proteome profiling highlighted a number of potential counter-regulatory effects of SAHA with respect to viral induction, which transcriptome profiling alone would not have identified. These observations could lead to a more informed selection and design of other HDACi with a more refined targeting profile, and prioritization of latency reversing agents of other classes to be used in combination with SAHA to achieve more potent induction of HIV expression.

journal_name

Antiviral Res

journal_title

Antiviral research

authors

White CH,Johnston HE,Moesker B,Manousopoulou A,Margolis DM,Richman DD,Spina CA,Garbis SD,Woelk CH,Beliakova-Bethell N

doi

10.1016/j.antiviral.2015.09.002

subject

Has Abstract

pub_date

2015-11-01 00:00:00

pages

78-85

eissn

0166-3542

issn

1872-9096

pii

S0166-3542(15)00213-2

journal_volume

123

pub_type

杂志文章
  • Effect of interferon on herpes simplex virus replication in murine macrophage-like cell lines.

    abstract::The effect of interferon on the replication of herpes simplex virus types 1 and 2 was studied in two murine macrophage-like cell lines which differ in their ability to synthesize interferon. Higher titers of herpes simplex virus type 1 occurred in PU5-1.8 cell cultures where interferon was not produced than in J774A.1...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(86)90010-0

    authors: Salo RJ,Ortega AP

    更新日期:1986-05-01 00:00:00

  • Functional analysis of influenza RNA polymerase activity by the use of caps, oligonucleotides and polynucleotides.

    abstract::The effects of caps, dinucleotides, oligonucleotides and polynucleotides on influenza virus RNA polymerase activity have been investigated. The results show that both methyl groups in a cap are necessary for optimal stimulation of polymerase activity. Both m7G(5')ppp(5')Am and ApG stimulated the influenza RNA polymera...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(81)90036-x

    authors: Stridh S,Oberg B,Chattopadhyaya J,Josephson S

    更新日期:1981-06-01 00:00:00

  • A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.

    abstract::The role of humoral response in the effective control of infection by influenza viruses is well known, but the protection is usually limited to the infecting or vaccinating isolate and to few related strains. Recent studies have evidenced the existence of B-cell epitopes broadly conserved among different influenza sub...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2011.07.013

    authors: Mancini N,Solforosi L,Clementi N,De Marco D,Clementi M,Burioni R

    更新日期:2011-10-01 00:00:00

  • Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies.

    abstract::Global eradication of hepatitis C virus (HCV) infection will require an efficacious vaccine capable of eliciting protective immunity against genetically diverse HCV strains. Natural spontaneous resolution of HCV infection is associated with production of broadly-neutralizing antibodies targeting the HCV glycoproteins ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2018.09.005

    authors: Tarr AW,Backx M,Hamed MR,Urbanowicz RA,McClure CP,Brown RJP,Ball JK

    更新日期:2018-12-01 00:00:00

  • Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.

    abstract::In a previous study a 15-mer phosphorothioate oligonucleotide (S-ON) derived from the packaging signal in the 5' end of segment 1 (PB2) of influenza A virus (designated 5-15b) proved markedly inhibitory to virus replication. Here we investigated whether analogous inhibitory S-ONs targeting the 5' end of segments 2 (PB...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.06.013

    authors: Giannecchini S,Wise HM,Digard P,Clausi V,Del Poggetto E,Vesco L,Puzelli S,Donatelli I,Azzi A

    更新日期:2011-10-01 00:00:00

  • Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.

    abstract::Anti-herpes simplex virus (HSV) activities of oxyresveratrol in vitro and topical administration in cutaneous HSV-1 infection in mice were examined. The inhibitory concentrations for 50% plaque formation (IC(50)) of oxyresveratrol against HSV-1 clinical isolates and HSV-2 clinical isolates were 20.9-29.5 and 22.2-27.5...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.05.013

    authors: Lipipun V,Sasivimolphan P,Yoshida Y,Daikoku T,Sritularak B,Ritthidej G,Likhitwitayawuid K,Pramyothin P,Hattori M,Shiraki K

    更新日期:2011-08-01 00:00:00

  • Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses.

    abstract::Based on genome-scale loss-of-function screens we discovered that Topoisomerase III-β (TOP3B), a human topoisomerase that acts on DNA and RNA, is required for yellow fever virus and dengue virus-2 replication. Remarkably, we found that TOP3B is required for efficient replication of all positive-sense-single stranded R...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104874

    authors: Prasanth KR,Hirano M,Fagg WS,McAnarney ET,Shan C,Xie X,Hage A,Pietzsch CA,Bukreyev A,Rajsbaum R,Shi PY,Bedford MT,Bradrick SS,Menachery V,Garcia-Blanco MA

    更新日期:2020-10-01 00:00:00

  • Chemotherapy of Aujeszky's disease (pseudorabies) in the mouse by means of nucleoside analogues: bromovinyldeoxyuridine, acyclovir, and dihydroxypropoxymethylguanine.

    abstract::Pseudorabies virus (PRV) infection was established in mice by means of inoculating the ear flap. The infection was universally fatal once clinical signs appeared. Bromovinyldeoxyuridine (BVDU) was a potent inhibitor of PRV in vitro, but this drug failed to protect mice and produced only marginal reductions in virus ti...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(85)90048-8

    authors: Field HJ

    更新日期:1985-06-01 00:00:00

  • Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent.

    abstract::Current therapies for chronic hepatitis B virus infection (CHB) - nucleos(t)ide analogue reverse transcriptase inhibitors and interferons - result in low rates of functional cure defined as sustained off-therapy seroclearance of hepatitis B surface antigen (HBsAg). One likely reason is the inability of these therapies...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2015.06.019

    authors: Gish RG,Yuen MF,Chan HL,Given BD,Lai CL,Locarnini SA,Lau JY,Wooddell CI,Schluep T,Lewis DL

    更新日期:2015-09-01 00:00:00

  • Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro.

    abstract::One of the plant extracts, glycyrrhizin (GL) was investigated for its antiviral action on varicella-zoster virus (VZV) in vitro. When human embryonic fibroblast (HEF) cells were treated with GL after inoculation of virus (post-treatment), the average 50%-inhibitory dose (ID50) for five VZV strains was 0.71 mM, and the...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(87)90025-8

    authors: Baba M,Shigeta S

    更新日期:1987-02-01 00:00:00

  • The interplay between antiviral activity, oligonucleotide hybridisation and nucleic acids incorporation studies.

    abstract::Nucleoside analogues have been the most successful antiviral compounds. Likewise, they are the most intriguing antiviral compounds, because of their structural relationship to natural nucleosides. This is also the reason why the design process of a potential selective antiviral nucleoside is so difficult. Too many nat...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2006.04.004

    authors: Herdewijn P

    更新日期:2006-09-01 00:00:00

  • Antiviral agents alter ability of HSV-2 to disrupt gap junctional intercellular communication between mammalian cells in vitro.

    abstract::In cultured mammalian cells (Vero), different antiviral agents change to differing degrees the ability of HSV2 to down-regulate gap junctions, each agent having a specific effect. Measured by intracellular electrodes, control cell populations showed 49-51% coupling, uninfected populations treated with acyclovir or SDS...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(02)00106-7

    authors: Musée J,Mbuy GN,Woodruff RI

    更新日期:2002-11-01 00:00:00

  • Retinoic acid receptor β, a potential therapeutic target in the inhibition of adenovirus replication.

    abstract::Human adenoviruses (HAdVs) usually cause mild respiratory infections, but they can also lead to fatal outcomes for immunosuppressive patients. Unfortunately, there has been no specific anti-HAdV drug approved for medical use. A better understanding of the nature of virus-host interactions during infection is beneficia...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2018.01.014

    authors: Wang X,Zhang Q,Zhou Z,Liu M,Chen Y,Li J,Xu L,Guo J,Li Q,Yang J,Wang S

    更新日期:2018-04-01 00:00:00

  • Baculovirus AcMNPV induces type I interferons and NK/NKT cells-mediated protection against foot-and-mouth disease virus in mice.

    abstract::Foot-and-mouth disease is a viral illness that affects cloven-hoofed animals causing serious economic losses. Inactivated vaccines against its causative agent, foot-and-mouth disease virus (FMDV), require approximately seven days to induce protection. Therefore, antiviral strategies are needed to provide earlier prote...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104850

    authors: Molina GN,Cacciabue M,Gismondi MI,Taboga O,Molinari P

    更新日期:2020-08-01 00:00:00

  • A murine model of coxsackievirus A16 infection for anti-viral evaluation.

    abstract::Coxsackievirus A16 (CA16) is one of the main causative agents of hand, foot and mouth disease (HFMD), which is a common infectious disease in children. CA16 infection may lead to severe nervous system damage and even death in humans. However, study of the pathogenesis of CA16 infection and development of vaccines and ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2014.02.015

    authors: Liu Q,Shi J,Huang X,Liu F,Cai Y,Lan K,Huang Z

    更新日期:2014-05-01 00:00:00

  • Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.

    abstract::A fatty acid derivative of ganciclovir (GCV), elaidic acid ganciclovir (E-GCV), has been evaluated for its inhibitory activity against laboratory and clinical strains of herpes simplex type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) in human embryonic lung fibroblasts. ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(00)00070-x

    authors: Andrei G,Snoeck R,Neyts J,Sandvold ML,Myhren F,De Clercq E

    更新日期:2000-03-01 00:00:00

  • Novel screening systems for HIV-1 fusion mediated by two extra-virion heptad repeats of gp41.

    abstract::Entry of human immunodeficiency virus type 1 (HIV-1) into target cells is mediated by its envelope protein gp41 through membrane fusion. Interaction of two extra-virion heptad repeats (HRs) in the gp41 plays a pivotal role in the fusion, and its inhibitor, enfuvirtide (T-20), blocks HIV-1 entry. To identify agents tha...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2008.05.006

    authors: Nishikawa H,Kodama E,Sakakibara A,Fukudome A,Izumi K,Oishi S,Fujii N,Matsuoka M

    更新日期:2008-10-01 00:00:00

  • Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.

    abstract::In the present study, the protective effect of 1T1, a lambda-carrageenan extracted from the red seaweed Gigartina skottsbergii was evaluated in a murine model of herpes simplex virus type 2 (HSV-2) genital infection. Six to eight-week-old female BALB/c mice were intravaginally inoculated with a lethal dose of HSV-2 (M...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2004.07.001

    authors: Carlucci MJ,Scolaro LA,Noseda MD,Cerezo AS,Damonte EB

    更新日期:2004-11-01 00:00:00

  • Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells.

    abstract::Although alpha interferon (IFN-alpha) is of benefit in the treatment of viral hepatitis B, HBV replication has been refractory to the cytokine in commonly used hepatocyte-derived cell lines. In search for a cell culture system to study the mechanism by which IFN-alpha inhibits HBV replication, we infected a variety of...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2007.06.015

    authors: Guo JT,Zhou T,Guo H,Block TM

    更新日期:2007-12-01 00:00:00

  • Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options.

    abstract::An estimated 15-20 million individuals are co-infected by hepatitis B and hepatitis D virus worldwide and are at high risk of developing end-stage liver disease, including hepatocellular carcinoma. While HBV viremia can now be controlled in the vast majority of individuals by nucleoside analogs, leading to a delay of ...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2015.08.009

    authors: Alfaiate D,Dény P,Durantel D

    更新日期:2015-10-01 00:00:00

  • A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.

    abstract::Development of efficient and safer vaccines against foot-and-mouth disease virus (FMDV) is a must. Previous results obtained in our laboratory have demonstrated that DNA vaccines encoding B and T cell epitopes from type C FMDV, efficiently controlled virus replication in mice, while they did not protect against FMDV c...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.07.017

    authors: Borrego B,Argilaguet JM,Pérez-Martín E,Dominguez J,Pérez-Filgueira M,Escribano JM,Sobrino F,Rodriguez F

    更新日期:2011-11-01 00:00:00

  • Recombinant full-length human cytomegalovirus protease has lower activity than recombinant processed protease domain in purified enzyme and cell-based assays.

    abstract::Herpesviruses encode a protease that is essential for virus replication. The protease undergoes cleavage to a processed form during capsid maturation. A recombinant 75 kDa form of the protease from human cytomegalovirus was purified and compared with the recombinant 29 kDa processed form. Modification with an active s...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(02)00051-7

    authors: Wittwer AJ,Funckes-Shippy CL,Hippenmeyer PJ

    更新日期:2002-08-01 00:00:00

  • T cell responses in hepatitis C virus infection: historical overview and goals for future research.

    abstract::Hepatitis C virus (HCV)-specific T cells are key factors in the outcome of acute HCV infection and in protective immunity. This review recapitulates the steps that immunologists have taken in the past 25years to dissect the role of T cell responses in HCV infection. It describes technical as well as disease-specific c...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2014.11.009

    authors: Holz L,Rehermann B

    更新日期:2015-02-01 00:00:00

  • The use of sialidase therapy for respiratory viral infections.

    abstract::DAS181 is an inhaled bacterial sialidase which functions by removing sialic acid (Sia) from the surface of epithelial cells, preventing attachment and subsequent infection by respiratory viruses that utilize Sia as a receptor. DAS181 is typical of bacterial sialidases in cleaving Sia α2-3 and Sia α2-6 linkages, and it...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2013.04.012

    authors: Nicholls JM,Moss RB,Haslam SM

    更新日期:2013-06-01 00:00:00

  • 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.

    abstract::The dengue fever virus (DENV) and the yellow fever virus (YFV) are members of the genus flavivirus in the family Flaviviridae. An estimated 50-100 million cases of DENV infections occur each year and approximately half a million patients require hospitalization. There is no vaccine or effective antiviral treatment ava...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.01.011

    authors: De Burghgraeve T,Selisko B,Kaptein S,Chatelain G,Leyssen P,Debing Y,Jacobs M,Van Aerschot A,Canard B,Neyts J

    更新日期:2013-05-01 00:00:00

  • Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process.

    abstract::On the basis of three different models (namely: ddU, AZT and PMEA), mononucleotide phosphotriester derivatives were designed to be able to liberate the corresponding monophosphate (or phosphonate) inside the cell through a reductase-mediated activation process. It was demonstrated that the use of bis[S-(2-hydroxyethyl...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(93)90093-x

    authors: Puech F,Gosselin G,Lefebvre I,Pompon A,Aubertin AM,Kirn A,Imbach JL

    更新日期:1993-10-01 00:00:00

  • Inhibition of heat-shock protein 90 reduces Ebola virus replication.

    abstract::Ebola virus (EBOV), a negative-sense RNA virus in the family Filoviridae, is known to cause severe hemorrhagic fever in humans and other primates. Infection with EBOV causes a high mortality rate and currently there is no FDA-licensed vaccine or therapeutic treatment available. Recently, heat-shock protein 90 (Hsp90),...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2010.04.015

    authors: Smith DR,McCarthy S,Chrovian A,Olinger G,Stossel A,Geisbert TW,Hensley LE,Connor JH

    更新日期:2010-08-01 00:00:00

  • Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide.

    abstract::Foot-and-mouth disease virus (FMDV) causes a highly contagious disease of cloven-hoofed animals. We have reported (Cubillos et al., 2008) that a synthetic dendrimeric peptide consisting of four copies of a B-cell epitope [VP1(136-154)] linked through thioether bonds to a T-cell epitope [3A(21-35)] of FMDV [B4T(thi)] e...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.03.005

    authors: Blanco E,Guerra B,de la Torre BG,Defaus S,Dekker A,Andreu D,Sobrino F

    更新日期:2016-05-01 00:00:00

  • Reverse genetics approaches to combat pathogenic arenaviruses.

    abstract::Several arenaviruses cause hemorrhagic fever (HF) in humans, and evidence indicates that the worldwide-distributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is a neglected human pathogen of clinical significance. Moreover, arenaviruses pose a biodefense threat. No licensed anti-arenavirus vaccine...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2008.08.002

    authors: de la Torre JC

    更新日期:2008-12-01 00:00:00

  • Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.

    abstract::In the event of a bioterror attack with variola virus (smallpox), exposure may only be identified following onset of fever. To determine if antiviral therapy with brincidofovir (BCV; CMX001) initiated at, or following, onset of fever could prevent severe illness and death, a lethal rabbitpox model was used. BCV is in ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2017.04.002

    authors: Grossi IM,Foster SA,Gainey MR,Krile RT,Dunn JA,Brundage T,Khouri JM

    更新日期:2017-07-01 00:00:00